Primo N Lara

Primo N Lara

UNVERIFIED PROFILE

Are you Primo N Lara?   Register this Author

Register author
Primo N Lara

Primo N Lara

Publications by authors named "Primo N Lara"

Are you Primo N Lara?   Register this Author

100Publications

1705Reads

19Profile Views

Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.

Cancer 2019 Nov 9;125(21):3853-3863. Epub 2019 Aug 9.

Division of Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32290DOI Listing
November 2019

A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer Registry.

Clin Lung Cancer 2019 Jun 14. Epub 2019 Jun 14.

Division of Hematology and Oncology, Department of Internal Medicine, UC Davis School of Medicine, UC Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.06.005DOI Listing
June 2019

Cytoreductive Nephrectomy in Metastatic Renal Cell Cancer: Not All That It's Cut Out to Be.

JAMA Oncol 2019 Feb;5(2):171-172

UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.5503DOI Listing
February 2019

Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study.

Clin Genitourin Cancer 2018 12 12;16(6):421-428.e1. Epub 2018 Jul 12.

Division of Hematology Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450697PMC
December 2018

Editorial Comment.

J Urol 2018 11 19;200(5):1003. Epub 2018 Jul 19.

University of California Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.06.071DOI Listing
November 2018

In Search of an Oncogene Driver for Squamous Lung Cancer.

JAMA Oncol 2018 09;4(9):1197-1198

University of California Davis Comprehensive Cancer Center, Sacramento.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0774DOI Listing
September 2018

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Cell 2018 07 19;174(3):758-769.e9. Epub 2018 Jul 19.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.06.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425931PMC
July 2018

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.

J Pharmacol Exp Ther 2018 06 30;365(3):494-506. Epub 2018 Mar 30.

Department of Biochemistry and Molecular Medicine (P.Y.H., Z.D., N.B., J.L.J., M.-J.T., H.-W.C., A.-M.Y.), Division of Hematology Oncology (T.W.), Department of Internal Medicine (P.N.L.), and Department of Urology (R.W.D.W.), UC Davis School of Medicine, Sacramento, California; Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York (J.-X.Q.); and Center for Computational Research, New York State Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, New York (Z.H.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.247775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931433PMC
June 2018

Modern Systemic Therapy for Metastatic Renal Cell Carcinoma of the Clear Cell Type.

Annu Rev Med 2018 01 16;69:209-221. Epub 2017 Nov 16.

Comprehensive Cancer Center, University of California at Davis, Sacramento, California 95819; email: ,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-041916-124132DOI Listing
January 2018

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.

Lung Cancer 2017 10 31;112:165-168. Epub 2017 Aug 31.

University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.015DOI Listing
October 2017

Metabolic reprogramming in clear cell renal cell carcinoma.

Nat Rev Nephrol 2017 07 8;13(7):410-419. Epub 2017 May 8.

Division of Nephrology, University of California Davis, Genome and Biomedical Sciences Facility, Room 6311, 451 Health Sciences Drive, Davis, California 95616, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2017.59DOI Listing
July 2017

Kidney Cancer: A New Forum for Impactful Scientific Interactions.

Kidney Cancer 2017 Jul 26;1(1). Epub 2017 Jul 26.

Radboud University Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/KCA-179001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179109PMC
July 2017

Kidney Cancer Incidence in California: End of the Trend?

Kidney Cancer 2017 Jul 26;1(1):71-81. Epub 2017 Jul 26.

California Cancer Reporting and Epidemiologic Surveillance (CalCARES) Program, Institute for Population Health Improvement, University of California Davis Health System, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://www.medra.org/servlet/aliasResolver?alias=iospress&am
Publisher Site
http://dx.doi.org/10.3233/KCA-170005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179112PMC
July 2017

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2017 May 21;18(3):281-285. Epub 2016 Nov 21.

Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Davis, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837026PMC
May 2017

Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.

World J Urol 2017 Feb 15;35(2):277-283. Epub 2016 Jun 15.

Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-016-1870-yDOI Listing
February 2017

Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer.

Clin Lung Cancer 2017 01 24;18(1):1-4. Epub 2016 Dec 24.

University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304163038
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2016.12.011DOI Listing
January 2017

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer.

J Clin Oncol 2016 11;34(31):3717-3718

Jonathan W. Riess, Primo N. Lara Jr, and David R. Gandara, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477925PMC
November 2016

Local Radiation for Extensive Stage Small Cell Lung Cancer: A Step Forward or Running in Place?

Clin Lung Cancer 2016 07;17(4):237-8

University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.06.001DOI Listing
July 2016

A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.

Cancer 2016 06 28;122(12):1897-904. Epub 2016 Mar 28.

Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892938PMC
June 2016

New and emerging developments in extensive-stage small cell lung cancer therapeutics.

Curr Opin Oncol 2016 Mar;28(2):97-103

aDivision of Hematology-Oncology, Department of Internal Medicine, University of California Davis School of Medicine bUniversity of California Davis Comprehensive Cancer Center, Sacramento, California, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2016/03000/New_and_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139911PMC
March 2016

Renal-Cell Cancer--Targeting an Immune Checkpoint or Multiple Kinases.

N Engl J Med 2015 Nov 25;373(19):1872-4. Epub 2015 Sep 25.

From the University of Southern California Norris Comprehensive Cancer Center, Los Angeles (D.I.Q.), and the University of California Davis Comprehensive Cancer Center, Sacramento (P.N.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1511252DOI Listing
November 2015

Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1421-9

*Department of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA; †Department of Internal Medicine, University of Maryland, College Park, MD; ‡Department of Oncology, Lombardi Comprehensive Cancer Center of the Georgetown University, Washington, DC; §Department of Biostatistics, University of California, Davis, CA; ‖Division of Medical Oncology, Swedish Cancer Institute, Seattle, WA; ¶Department of Internal Medicine, Swedish Cancer Institute, Seattle, WA; #Department of Internal Medicine, Comprehensive Cancer Center, University of California, Davis, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153351
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000508DOI Listing
October 2015

Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap.

J Clin Oncol 2015 Sep 27;33(26):2839-40. Epub 2015 Jul 27.

University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.9692DOI Listing
September 2015

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results.

Int J Clin Oncol 2015 Jun 5;20(3):518-24. Epub 2014 Aug 5.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-014-0730-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318776PMC
June 2015

Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer".

J Thorac Oncol 2015 May;10(5):e36

University of California Davis Comprehensive Cancer Center, Sacramento, CA SWOG Statistical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000515DOI Listing
May 2015

Squamous cell lung cancer: from tumor genomics to cancer therapeutics.

Clin Cancer Res 2015 May;21(10):2236-43

Department of Medicine (Medical Oncology) and Pathology, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862209PMC
May 2015

Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines.

J Cancer Res Clin Oncol 2015 Apr 17;141(4):615-26. Epub 2014 Oct 17.

Comprehensive Cancer Center, University of California, Davis, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1855-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562434PMC
April 2015

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.

J Thorac Oncol 2015 Jan;10(1):110-5

*University of California Davis Comprehensive Cancer Center, Sacramento, California; †SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Washington; ‡Humboldt Medical Specialists, Eureka, California; and §Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320001PMC
January 2015

Prostate cancer: Predicting response to androgen receptor signalling inhibition.

Nat Rev Urol 2014 Aug 22;11(8):433-5. Epub 2014 Jul 22.

Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2014.179DOI Listing
August 2014

Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer.

J Thorac Cardiovasc Surg 2014 Jul 19;148(1):36-40. Epub 2014 Mar 19.

Section of General Thoracic Surgery, University of California, Davis Medical Center, Sacramento, Calif.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2014.03.014DOI Listing
July 2014

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.

J Natl Cancer Inst 2014 Apr 24;106(4):dju013. Epub 2014 Feb 24.

Affiliations of authors: University of California Davis Comprehensive Cancer Center, Sacramento, CA (PNL, PCM); Southwest Oncology Group Statistical Center, Seattle, WA (BE, CT); University of Southern California Norris Cancer Center, Los Angeles, CA (DIQ, AG); USDA Western Human Nutrition Center at University of California Davis, Davis, CA (EG, MVL); City of Hope, Duarte, CA (PT); University of Michigan, Ann Arbor, MI (MH), US Oncology, Las Vegas, NV (NJV); Cancer Treatment and Research Center, University of Texas, San Antonio, TX (IT).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982883PMC
April 2014

Papillary renal cell carcinoma: current progress and future directions.

Clin Genitourin Cancer 2014 Apr 13;12(2):74-9. Epub 2013 Nov 13.

Southwest Oncology Group, Portland, OR; Division of Hematology/Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.11.013DOI Listing
April 2014

Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.

Cancer 2014 Apr;120 Suppl 7:1091-6

Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, California; Cancer Control, University of California, Davis Comprehensive Cancer Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28575DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980490PMC
April 2014

Left behind? Drug discovery in extensive-stage small-cell lung cancer.

Clin Lung Cancer 2014 Mar 3;15(2):93-5. Epub 2014 Jan 3.

University of California Davis School of Medicine and UC Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184801PMC
March 2014

Dasatinib and docetaxel in advanced prostate cancer.

Lancet Oncol 2013 Dec 8;14(13):1248-9. Epub 2013 Nov 8.

Division of Hematology Oncology, Department of Internal Medicine, Sacramento, CA 95817, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70500-XDOI Listing
December 2013

Evolving epidemiologic trends in nonclear cell renal cell cancer: an analysis of the California Cancer Registry.

Urology 2013 Oct;82(4):840-5

Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.07.020DOI Listing
October 2013

Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors.

Anticancer Drugs 2013 Jul;24(6):636-40

Department of Internal Medicine, Division of Hematology/Oncology, University of California, Davis, Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3283618b7bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153755PMC
July 2013

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.

Int J Nanomedicine 2012 6;7:2793-804. Epub 2012 Jun 6.

Division of Hematology and Oncology, Department of Internal Medicine, University of California- Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJN.S27734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383352PMC
January 2013

Efficacy and toxicity differences in lung cancer populations in the era of clinical trials globalization: the 'common arm' approach.

Expert Rev Anticancer Ther 2012 Dec;12(12):1591-6

Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.135DOI Listing
December 2012

Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors.

Invest New Drugs 2012 Oct 21;30(5):2001-7. Epub 2011 Oct 21.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Cancer Center, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-011-9761-y
Publisher Site
http://dx.doi.org/10.1007/s10637-011-9761-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131984PMC
October 2012

Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach.

Urol Oncol 2012 Sep 2;30(5):635-45. Epub 2010 Oct 2.

Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis Cancer Center, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2010.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572726PMC
September 2012

Progress in personalizing chemotherapy for bladder cancer.

Adv Urol 2012 13;2012:364919. Epub 2012 Feb 13.

Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/364919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287014PMC
August 2012

Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.

Clin Genitourin Cancer 2012 Jun 28;10(2):93-8. Epub 2012 Feb 28.

Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2012.01.007DOI Listing
June 2012

Defining an individualized treatment strategy for metastatic renal cancer.

Urol Clin North Am 2012 May 3;39(2):233-49, vii. Epub 2012 Mar 3.

Department of Urology, University of California, Davis, Medical Center, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2012.02.002DOI Listing
May 2012

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.

Invest New Drugs 2012 Apr 22;30(2):741-8. Epub 2010 Oct 22.

Division of Hematology & Oncology, University of California Davis Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-010-9562-8
Publisher Site
http://dx.doi.org/10.1007/s10637-010-9562-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277821PMC
April 2012

Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.

Cancer Chemother Pharmacol 2012 Jan 5;69(1):185-94. Epub 2011 Jun 5.

University of California, Davis Cancer Center, 4501 X Street, Suite, 3016, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1684-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562405PMC
January 2012

XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib.

J Thorac Oncol 2012 Jan;7(1):219-26

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31822eebf9DOI Listing
January 2012

A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma.

Int J Clin Oncol 2011 Oct 23;16(5):494-9. Epub 2011 Mar 23.

University of California Davis Cancer Center, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-011-0212-8DOI Listing
October 2011

Secondary malignancies among nonseminomatous germ cell tumor cancer survivors.

Cancer 2011 Sep 15;117(18):4219-30. Epub 2011 Mar 15.

Department of Urology, University of California, Los Angeles, Los Angeles, California 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26038DOI Listing
September 2011

Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer.

Curr Opin Oncol 2011 Mar;23(2):150-7

Department of Medical Oncology and Clinical Research, University Hospital Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328341ee38DOI Listing
March 2011

Enhancing the clinical activity of sorafenib through dose escalation: rationale and current experience.

Ther Adv Med Oncol 2011 Mar;3(2):95-100

University of California, Davis - Hematology/Oncology, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834010396117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126039PMC
March 2011

Medical oncology: Chemoradiotherapy for NSCLC-does a 'standard' exist?

Nat Rev Clin Oncol 2011 Jan 23;8(1):5-6. Epub 2010 Nov 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2010.191DOI Listing
January 2011

Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer.

J Thorac Oncol 2010 Dec;5(12):1933-8

Division of Hematology/Oncology, University of California Davis Cancer Center, Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181fd418dDOI Listing
December 2010

Racial disparities on the use of invasive and noninvasive staging in patients with non-small cell lung cancer.

J Thorac Oncol 2010 Nov;5(11):1772-8

UC Davis Cancer Center, Division of Biostatistics, Department of Public Health Sciences, UC Davis, California Cancer Registry, University of California Davis Health System, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181f69f22DOI Listing
November 2010

Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.

Chem Res Toxicol 2010 Nov 28;23(11):1653-5. Epub 2010 Oct 28.

Division of Hematology & Oncology, Department of Internal Medicine, UC Davis Cancer Center, Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/tx1003547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987236PMC
November 2010

[Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012].

Zhongguo Fei Ai Za Zhi 2010 Mar;13(3):238-41

Division of Hematology and Oncology, University of California Davis Cancer Center, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.03.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136060PMC
March 2010